Susquehanna International Group, LLP Mirum Pharmaceuticals, Inc. Transaction History

Susquehanna International Group, LLP

$560 Billion
Q3 2024

A detailed history of Susquehanna International Group, LLP transactions in Mirum Pharmaceuticals, Inc. stock. As of the latest transaction made, Susquehanna International Group, LLP holds 15,593 shares of MIRM stock, worth $660,987. This represents 0.0% of its overall portfolio holdings.

Number of Shares

15,593

Previous 34,963 55.4%

Holding current value

$660,987

Previous $1.2 Million 49.12%

% of portfolio

0.0%

Previous 0.0%

15 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 14, 2024	SELL	$33.68 - $44.74 $652,381 - $866,613	-19,370 Reduced 55.4%	15,593 $608,000
Q2 2024 Aug 15, 2024	BUY	$23.57 - $34.85 $250,030 - $369,688	10,608 Added 43.56%	34,963 $1.2 Million
Q1 2024 May 07, 2024	BUY	$24.92 - $30.02 $398 - $480	16 Added 0.07%	24,355 $611,000
Q4 2023 Feb 14, 2024	SELL	$27.14 - $34.93 $231,069 - $297,394	-8,514 Reduced 25.92%	24,339 $718,000
Q3 2023 Nov 14, 2023	BUY	$24.63 - $32.85 $393,759 - $525,172	15,987 Added 94.79%	32,853 $1.04 Million
Q2 2023 Aug 11, 2023	SELL	$23.51 - $30.09 $1.22 Million - $1.56 Million	-51,881 Reduced 75.47%	16,866 $436,000
Q1 2023 May 16, 2023	BUY	$19.19 - $24.1 $919,201 - $1.15 Million	47,900 Added 229.77%	68,747 $1.65 Million
Q4 2022 Feb 14, 2023	SELL	$17.59 - $23.83 $105,434 - $142,837	-5,994 Reduced 22.33%	20,847 $406,000
Q3 2022 Nov 14, 2022	SELL	$19.98 - $29.44 $22,017 - $32,442	-1,102 Reduced 3.94%	26,841 $564,000
Q2 2022 Aug 15, 2022	BUY	$18.42 - $27.5 $61,449 - $91,740	3,336 Added 13.56%	27,943 $544,000
Q1 2022 May 16, 2022	BUY	$15.5 - $23.93 $10,230 - $15,793	660 Added 2.76%	24,607 $542,000
Q4 2021 Feb 14, 2022	SELL	$13.05 - $19.35 $828,035 - $1.23 Million	-63,451 Reduced 72.6%	23,947 $382,000
Q3 2021 Nov 15, 2021	BUY	$13.95 - $20.18 $1.07 Million - $1.55 Million	76,987 Added 739.48%	87,398 $1.74 Million
Q2 2021 Aug 11, 2021	SELL	$15.84 - $20.6 $46,601 - $60,605	-2,942 Reduced 22.03%	10,411 $180,000
Q1 2021 May 17, 2021	BUY	$16.29 - $21.92 $217,520 - $292,697	13,353 New	13,353 $265,000

Others Institutions Holding MIRM

# of Institutions

190

Shares Held

54M

Call Options Held

177K

Put Options Held

167K

View Full List

About Mirum Pharmaceuticals, Inc.

Ticker MIRM
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 36,751,700
Market Cap $1.56B
Description
Mirum Pharmaceuticals, Inc., a biopharmaceutical company, focuses on the development and commercialization of novel therapies for debilitating rare and orphan diseases. The company's lead product candidate is LIVMARLI, an investigational oral drug for the treatment of progressive familial intrahepatic cholestasis disease, as well as for the trea...

More about MIRM

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Susquehanna International Group, LLP, based on Form 13F filings with the SEC.

News

Stay updated on Susquehanna International Group, LLP with notifications on news.

Account

Susquehanna International Group, LLP Mirum Pharmaceuticals, Inc. Transaction History